We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AG Deals Not Outlawed by 3rd Circuit’s Anti Pay-for-Delay Stance: Lower Court
AG Deals Not Outlawed by 3rd Circuit’s Anti Pay-for-Delay Stance: Lower Court
January 2, 2013
A New Jersey court has thrown out an antitrust lawsuit against Teva and GlaxoSmithKline, ruling that patent settlements that involve authorized generic agreements are not illegal.